WOCKPHARMA.BOWOCKPHARMA.BOBSE
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +2.85% | +4.64% | -0.14% | -3.34% | +23.16% |
| Gross Profit Growth | +15.04% | +15.63% | +11.27% | -39.45% | +24.40% |
| EBITDA Growth | +98.77% | +111.38% | +8.01% | +53.67% | +137.04% |
| Operating Income Growth | +19.43% | +74.46% | +13.91% | -69.52% | -63.39% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +321.43% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +296.70% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +296.70% |
| Weighted Average Shares Growth | +6.58% | +8.00% | +10.44% | +8.57% | +6.23% |
| Weighted Average Shares Diluted Growth | +6.58% | +9.67% | +10.44% | +8.57% | +6.23% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | -100.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | -100.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | +6.96% | +0.00% | -22.88% | +0.00% |
| Inventory Growth | +0.00% | +13.28% | +0.00% | +31.81% | +0.00% |
| Asset Growth | +0.00% | +6.35% | +0.00% | +12.45% | +0.00% |
| Book Value per Share Growth | +1.51% | +19.99% | +15.15% | +23.90% | +0.00% |
| Debt Growth | +0.00% | -11.38% | +0.00% | +4.82% | +0.00% |
| R&D Expense Growth | +0.00% | -9.85% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | +7.89% | +6.68% | +6.88% | +4.97% | -100.00% |